tiprankstipranks
Trending News
More News >

Agilon Health price target lowered to $5 from $6 at Wells Fargo

Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Agilon Health (AGL) to $5 from $6 and keeps an Overweight rating on the shares. The firm cites a “frustrating quarter” given the PYD issues. The thesis remains largely unchanged, with Wells continuing to see positive leverage to improving MA rates and downstream margin recovery story. The firm is lowering forward revenue/profit somewhat to account for Agilon’s expected trajectory.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1